Professional Summary

Professional Overview

Tejal Patel is an experienced regulatory affairs professional with a strong track record of driving successful product approvals and regulatory compliance in the pharmaceutical industry. As the Director of Regulatory Affairs at Pfizer, she leverages her in-depth knowledge of global regulatory frameworks and her ability to navigate complex regulatory landscapes to support the company's R&D pipeline and ensure the timely and compliant launch of new therapies.

Experience Summary

Current Role

Tejal currently serves as the Director of Regulatory Affairs at Pfizer, a role she has held since December 2023. In this position, she is responsible for leading a team of regulatory experts, overseeing the preparation and submission of regulatory dossiers, and collaborating with cross-functional stakeholders to ensure the seamless integration of regulatory requirements into the product development process. Tejal's expertise and strategic guidance have been instrumental in securing regulatory approvals for several of Pfizer's innovative drug candidates, contributing to the company's growth and patient access to new treatments.

Career Progression

Prior to her current role, Tejal held the position of Director Regulatory Affairs at Seagen, where she spearheaded the successful regulatory approval of a novel oncology drug in multiple markets. Before that, she served as the Senior Manager Regulatory Affairs at Amgen, where she played a pivotal role in navigating the regulatory landscape and supporting the company's pipeline expansion. Tejal's career began at GlaxoSmithKline, where she gained valuable experience as a Regulatory Project Manager, contributing to the successful submission and approval of several pharmaceutical products.

Academic Background

Tejal holds a Master's degree in Pharmaceutical Sciences from the University of London, with a specialization in Regulatory Affairs. Her academic achievements include several research publications and industry recognition for her contributions to the field of regulatory affairs.

Areas of Expertise

• Comprehensive understanding of global regulatory frameworks and guidelines

• Expertise in the preparation and submission of regulatory dossiers, including marketing authorization applications, clinical trial applications, and post-approval variations

• Skilled in navigating complex regulatory landscapes and collaborating with health authorities to ensure timely and compliant product approvals

• Proficient in managing cross-functional teams and leading strategic regulatory initiatives

• Proven track record in driving regulatory strategy and contributing to the successful development and commercialization of pharmaceutical products

Professional Impact

Throughout her career, Tejal has played a pivotal role in securing regulatory approvals for several innovative pharmaceutical products, contributing to improved patient access to cutting-edge therapies. Her strategic guidance and regulatory expertise have been instrumental in driving the growth and expansion of the companies she has worked for, and she is widely recognized as a thought leader in the field of regulatory affairs.

Conclusion

With her extensive experience, technical expertise, and strategic leadership, Tejal Patel is a highly valuable asset to Pfizer's regulatory affairs team. Her commitment to ensuring regulatory compliance and her ability to navigate the evolving regulatory landscape make her a valuable partner in the company's pursuit of bringing innovative and life-changing therapies to patients around the world.